Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations.
about
Oral high-dose atorvastatin treatment in relapsing-remitting multiple sclerosisMultiple sclerosis, relapses, and the mechanism of action of adrenocorticotropic hormoneCorticosteroids for the long-term treatment in multiple sclerosisReducing the probability of false positive research findings by pre-publication validation - experience with a large multiple sclerosis databaseNeuroendocrine immunoregulation in multiple sclerosisRisk Factors, Epidemiology and Treatment Strategies for Metabolic Bone Disease in Patients with Neurological Disease.Does pulse dosing of methylprednisolone have an acute effect on serum creatinine concentrations?Management of optic neuritisRelationship between Prolactin Plasma Levels and White Matter Volume in Women with Multiple SclerosisSystemic glucocorticoid therapy and adrenal insufficiency in adults: A systematic review.Diagnosis and treatment of multiple sclerosis in pediatric and adolescent patients: current status and future therapies.Fingolimod: an oral disease-modifying therapy for relapsing multiple sclerosis.Bone health in multiple sclerosis.Management of children with multiple sclerosis.Prolactin in multiple sclerosis.Adaptive immune responses in CNS autoimmune disease: mechanisms and therapeutic opportunities.Cuprizone-induced demyelination as a tool to study remyelination and axonal protection.Effect of Early and Prophylactic Nonsteroidal Anti-Inflammatory Drugs on Flare Duration in Pediatric Acute-Onset Neuropsychiatric Syndrome: An Observational Study of Patients Followed by an Academic Community-Based Pediatric Acute-Onset NeuropsychiaPrevalence of autoimmune disease in patients with prolactinomas and non-functioning pituitary adenomas.The clock keeps ticking for intravenous methylprednisolone.Slowly eroding lesions in multiple sclerosis.
P2860
Q21144329-CA32479A-3183-454A-9DB1-2574F46C9415Q21558407-E8D44408-A9C1-4549-B312-56CEAFE349BEQ24242150-E5C9A4AE-89C7-427C-9CFA-489E3AE67A2AQ24288959-33E25AC2-1A82-47AC-BEB9-A211EF78605BQ26864449-96B5647C-7C58-4EB7-83A9-BEFA670A2BE2Q30248491-5C512724-BB1D-413C-B737-03986F8231A7Q34764365-82179271-BA62-4662-8914-F524637CB8FCQ35049583-9D188DDE-7837-4CC2-BC10-3D5B746ECAB3Q35876713-AD0BB9C9-B9AE-45E0-9215-D686EC08CC6AQ37180423-BE03E23F-F782-4362-8097-1CB8DB24817DQ37562166-AF67F643-DCFE-4535-A50D-C85500805DD6Q37851885-2CD63E30-6E07-4A94-8112-C814E48FDE59Q37878397-A6E0B361-27D6-4AA1-A254-3B7CBD21AE60Q38002113-05EEF80F-6682-4CCB-9308-3E251F2BC6D7Q38039054-AFB9DBCC-C086-462E-BFB3-B45BE14712DBQ38097385-52DB2379-AC47-4C73-AF15-EF34A64B4E31Q38105989-E54118D4-C63C-423E-B347-928AA731A443Q38684263-8C56AC8C-4CB1-4DD4-9A21-8DD3A71D01C1Q40174707-DDAE9F72-EB6B-4CB0-8A88-9FA3F430E448Q42765791-FFB089A2-2D1F-4594-BD97-E0EE7D36FC29Q48658716-26F7D1C6-F639-46EC-8F3E-D792085157C1
P2860
Monthly intravenous methylprednisolone in relapsing-remitting multiple sclerosis - reduction of enhancing lesions, T2 lesion volume and plasma prolactin concentrations.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Monthly intravenous methylpred ...... asma prolactin concentrations.
@ast
Monthly intravenous methylpred ...... asma prolactin concentrations.
@en
type
label
Monthly intravenous methylpred ...... asma prolactin concentrations.
@ast
Monthly intravenous methylpred ...... asma prolactin concentrations.
@en
prefLabel
Monthly intravenous methylpred ...... asma prolactin concentrations.
@ast
Monthly intravenous methylpred ...... asma prolactin concentrations.
@en
P2093
P2860
P50
P356
P1433
P1476
Monthly intravenous methylpred ...... asma prolactin concentrations.
@en
P2093
Alexander Yassouridis
Axel Wismüller
Erina Schumann
Florian Then Bergh
Frank Weber
Martin Daumer
Michaela Schwan
Mirjana Blazevic
P2860
P2888
P356
10.1186/1471-2377-6-19
P577
2006-05-23T00:00:00Z
P5875
P6179
1037142371